课题基金 / 基金详情

Development of congenital anomalies of the kidney and urinary tract (CAKUT)

Development of congenital anomalies of the kidney and urinary tract (CAKUT)
肾脏和泌尿道先天性异常 (CAKUT) 的发展
批准号:
12307021
负责人:
ICHIKAWA Iekuni
金额:
$27.76万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2000
资助国家:
日本
项目状态:
已结题
起止时间:
2000 至 2003

项目摘要

项目成果

ICHIKAWA Iekuni的其他基金

相似基金

相关文献

中文摘要
翻译
据推测,最初的输尿管发芽异位是导致许多先天性肾和尿路畸形(CAKUT)的第一个个体错误。异位可导致肾发育不良、输尿管膀胱口异位、尿流出道梗阻和/或反流。我们对Bmp4/-、Foxc1-/-、Agtr2-/Y等突变小鼠模型的研究证实,异位输尿管萌芽确实发生在CAKUT形成之前。此外,我们还发现,作用于Wolffian管和输尿管上皮的BMP4通过局部拮抗来自后肾间充质的无处不在的诱导信号(S)来决定输尿管的出芽位置。然而,对Foxc1-/-的分析表明,尽管异位输尿管可以导致肾脏发育不良和输尿管形态异常,但它不会导致多囊发育不良肾的形成,这是一种在人类CAKUT中常见的肾脏异常。通常,参与导航输尿管萌发部位的基因也调节肾脏和其他尿路系统后来的个体发生过程。例如,BMP4在肾脏和尿路形成过程中具有多种生物学功能,如下所示。除了确定输尿管的萌发部位外,BMP4(1)刺激萌芽的输尿管延长,2)通过抑制细胞凋亡促进后肾间充质的生长,以及3)在肾小球形成过程中对肾小球簇状的形成起作用。因此,这些基因的这些附加功能构成了CAKUT广谱的基础,因为这些基因在多个个体发生阶段的多个位置表达,并通过其独特的细胞功能调节排泄系统许多部分的形态发生。
英文摘要
It has been postulated that ectopia of the initial ureter budding is the first ontogenic misstep that leads to many congenital anomalies of the kidney and urinary tract (CAKUT). The ectopia can result in hypoplastic kidney, ectopia of ureterovesical orifice, urinary outflow obstruction and/or reflux. Our studies on several mutant mouse models, e.g., Bmp4 +/-, Foxc1 -/-, Agtr2 -/Y, verified that ectopic ureter budding indeed occurs prior to the formation of CAKUT. Moreover we found that BMP4, acting on the Wolffian duct and ureter epithelium, determines the budding site of the ureter by locally antagonizing ubiquitous inductive signal(s) from the metanephric mesenchyme. However, analyses of Foxc1 -/-revealed that, whereas ectopic ureter can result in hypoplastic kidney and ureter morphological abnormality, it cannot cause formation of multicystic dysplastic kidney, a well-known renal abnormality seen in human CAKUT. Often, the genes involved in navigating the site of ureteral budding also regulate later ontogenic processes of the kidney and other urinary tract system. For example, BMP4 has multiple biological' functions during kidney and urinary tract formation as follows. In addition to determining budding site of the ureter, BMP4 (1) stimulates elongation of the budding ureter, 2) promotes growth of the metanephric mesenchyme by inhibiting apoptosis, and 3) has a role on the formation of glomerular tuft during glomerulogenesis. Thus, these additional functions of the genes underlie the wide spectrum of CAKUT, as the genes are expressed at multiple sites at multiple ontogenic stages, and regulate the morphogenesis of the many portions Qf the excretory system through their distinctive cellular functions.
期刊论文(48)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, Davidson JM, Linton MF, Fazio S, Homma T, Yoshida H, Ichikawa I: "Absence of angiotensin II type 1 receptor in bone marrow-derived cells is detrimental in the evolution of renal fibrosis"The Jou
Nishida M, Fujinaka H, Matsusaka T, Price J, Kon V, Fogo AB, Davidson JM, Linton MF, Fazio S, Homma T, Yoshida H, Ichikawa I:“骨髓来源细胞中缺乏血管紧张素 II 1 型受体
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oshima K, Miyazaki Y, Brock JW 3rd, Adams MC, Ichikawa I: "Angiotensin type II receptor expression and ureteral budding"The Journal of Urology. 166(5). 1848-1852 (2001)
Oshima K、Miyazaki Y、Brock JW 3rd、Adams MC、Ichikawa I:“血管紧张素 II 型受体表达和输尿管出芽”泌尿学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Oshima K, Miyazaki Y, Brock JW 3rd, Adams MC, Ichikawa I: "Angiotensin type II receptor expression and ureteral budding"Journal of Urology. 166(5). 1848-1852 (2001)
Oshima K、Miyazaki Y、Brock JW 3rd、Adams MC、Ichikawa I:“血管紧张素 II 型受体表达和输尿管出芽”泌尿学杂志。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
36
    Novel Approach for Treatment of Glomeruloclerosis
    • 批准号:
      23249047
    • 项目类别:
      Grant-in-Aid for Scientific Research (A)
    • 资助金额:
      $30.12万
    • 财政年份:
      2011
    • 负责人:
      ICHIKAWA Iekuni
    • 依托单位:
    glomerular sclerosis
    • 批准号:
      16109005
    • 项目类别:
      Grant-in-Aid for Scientific Research (S)
    • 资助金额:
      $68.72万
    • 财政年份:
      2004
    • 负责人:
      ICHIKAWA Iekuni
    • 依托单位:
    国内基金
    海外基金
    外泌体lncRNA TUG1通过miR-204-5p/FOXC1信号通路靶向调控HUVECs促进肝母细胞瘤血管生成的机制研究
    • 批准号:
      2026JJ81317
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      袁妙贤
    • 依托单位:
    巨噬细胞FOXC1调控TXNDC5活化参与脓毒症的机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2025
    • 负责人:
      曾燕萍
    • 依托单位:
    USP49通过去泛素化FOXC1促进肝癌有氧糖酵解和肿瘤进展的作用和机制研究